These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lack of funding could undermine UK antibiotic resistance strategy, say experts. O'Dowd A BMJ; 2013 Dec; 347():f7618. PubMed ID: 24355390 [No Abstract] [Full Text] [Related]
3. The drug-resistant bacteria that pose the greatest health threats. Willyard C Nature; 2017 Feb; 543(7643):15. PubMed ID: 28252092 [No Abstract] [Full Text] [Related]
5. Novel Programs and Discoveries Aim to Combat Antibiotic Resistance. Hampton T JAMA; 2015 Jun 23-30; 313(24):2411-3. PubMed ID: 26039283 [No Abstract] [Full Text] [Related]
6. Mechanisms of Bacterial Resistance to Antimicrobial Agents. van Duijkeren E; Schink AK; Roberts MC; Wang Y; Schwarz S Microbiol Spectr; 2018 Jan; 6(1):. PubMed ID: 29327680 [TBL] [Abstract][Full Text] [Related]
7. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents. Payne D; Tomasz A Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496 [No Abstract] [Full Text] [Related]
8. Methodology of prevention of antibiotic resistance. Shetty A J Assoc Physicians India; 2010 Dec; 58 Suppl():47-8. PubMed ID: 21568010 [No Abstract] [Full Text] [Related]
11. A rational approach to the selection of an antimicrobial agent. Hirsh DC; Ruehl WW J Am Vet Med Assoc; 1984 Nov; 185(10):1058-61. PubMed ID: 6392230 [No Abstract] [Full Text] [Related]
12. [Not Available]. Müller A Drug Res (Stuttg); 2018 Nov; 68(S 01):S6-S7. PubMed ID: 30453362 [No Abstract] [Full Text] [Related]
13. Inhibitors targeting two-component signal transduction. Watanabe T; Okada A; Gotoh Y; Utsumi R Adv Exp Med Biol; 2008; 631():229-36. PubMed ID: 18792693 [TBL] [Abstract][Full Text] [Related]
14. Development of novel antibacterial drugs to combat multiple resistant organisms. Bassetti M; Righi E Langenbecks Arch Surg; 2015 Feb; 400(2):153-65. PubMed ID: 25667169 [TBL] [Abstract][Full Text] [Related]
15. Bacterial infections: antibiotics and decontamination. Gould D Nurs Stand; 2004 Jun 16-22; 18(40):38-42. PubMed ID: 15224613 [TBL] [Abstract][Full Text] [Related]
16. Late stage antibacterial drugs in the clinical pipeline. Projan SJ; Bradford PA Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658 [TBL] [Abstract][Full Text] [Related]
17. Addressing antimicrobial resistance in the UK and Europe. Wells V; Piddock LJV Lancet Infect Dis; 2017 Dec; 17(12):1230-1231. PubMed ID: 29133171 [No Abstract] [Full Text] [Related]
18. Epidemiology and characteristics of antimicrobial resistance in China. Xiao YH; Giske CG; Wei ZQ; Shen P; Heddini A; Li LJ Drug Resist Updat; 2011; 14(4-5):236-50. PubMed ID: 21807550 [TBL] [Abstract][Full Text] [Related]
19. The impact of antimicrobial resistance and the challenge for professionals. Krummenauer EC; Carneiro M; Alves Machado JA; de Mello Rauber J; Adam MS; Muller LB; Persch MS; de Souza JG Am J Infect Control; 2013 Apr; 41(4):386-7. PubMed ID: 23062659 [No Abstract] [Full Text] [Related]
20. Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. Tenover FC Clin Infect Dis; 2007 Feb; 44(3):418-23. PubMed ID: 17205452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]